Shanghai ZJ Bio-Tech Co. Ltd. A (688317) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥6.85 Million ≈ $1.00 Million USD) by net assets (CN¥3.39 Billion ≈ $496.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Shanghai ZJ Bio-Tech Co. Ltd. A to measure how much of total assets are equity-financed.

Shanghai ZJ Bio-Tech Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai ZJ Bio-Tech Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Shanghai ZJ Bio-Tech Co. Ltd. A to evaluate the quality of earnings relative to operating cash generation.

Shanghai ZJ Bio-Tech Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai ZJ Bio-Tech Co. Ltd. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Phu Nhuan Jewelry JSC
VN:PNJ
-0.127x
Dolphin Drilling AS
OL:DDRIL
-0.040x
Shenzhen Asiantime International Construction Co Ltd
SHE:002811
0.071x
Comtec Sys
KO:031820
-0.007x
VersaBank
NASDAQ:VBNK
-0.112x
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
0.040x
Yulon Nissan Motor Co Ltd
TW:2227
-0.012x
TWC Enterprises Ltd
TO:TWC
0.081x

Annual Cash Flow Conversion Efficiency for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 688317 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.35 Billion
≈ $490.04 Million
CN¥66.85 Million
≈ $9.78 Million
0.020x -6.43%
2024-12-31 CN¥3.64 Billion
≈ $532.19 Million
CN¥77.59 Million
≈ $11.35 Million
0.021x +199.65%
2023-12-31 CN¥3.82 Billion
≈ $559.71 Million
CN¥-81.88 Million
≈ $-11.98 Million
-0.021x -115.37%
2022-12-31 CN¥4.20 Billion
≈ $614.65 Million
CN¥584.97 Million
≈ $85.60 Million
0.139x -16.97%
2021-12-31 CN¥3.83 Billion
≈ $560.07 Million
CN¥641.94 Million
≈ $93.94 Million
0.168x -78.52%
2020-12-31 CN¥1.46 Billion
≈ $214.02 Million
CN¥1.14 Billion
≈ $167.08 Million
0.781x +482.33%
2019-12-31 CN¥571.84 Million
≈ $83.68 Million
CN¥76.66 Million
≈ $11.22 Million
0.134x -11.44%
2018-12-31 CN¥532.66 Million
≈ $77.95 Million
CN¥80.63 Million
≈ $11.80 Million
0.151x +49.06%
2017-12-31 CN¥472.70 Million
≈ $69.17 Million
CN¥48.00 Million
≈ $7.02 Million
0.102x +10.36%
2016-12-31 CN¥483.90 Million
≈ $70.81 Million
CN¥44.53 Million
≈ $6.52 Million
0.092x +147.38%
2015-12-31 CN¥343.47 Million
≈ $50.26 Million
CN¥12.78 Million
≈ $1.87 Million
0.037x -85.11%
2014-12-31 CN¥110.35 Million
≈ $16.15 Million
CN¥27.57 Million
≈ $4.03 Million
0.250x +4.71%
2013-12-31 CN¥118.03 Million
≈ $17.27 Million
CN¥28.16 Million
≈ $4.12 Million
0.239x --

About Shanghai ZJ Bio-Tech Co. Ltd. A

SHG:688317 China Medical Devices
Market Cap
$467.90 Million
CN¥3.20 Billion CNY
Market Cap Rank
#12576 Global
#3679 in China
Share Price
CN¥16.64
Change (1 day)
-0.42%
52-Week Range
CN¥15.05 - CN¥28.98
All Time High
CN¥80.15
About

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.